dc.date.accessioned2018-12-07T13:32:46Z
dc.date.accessioned2022-10-18T21:54:44Z
dc.date.available2018-12-07T13:32:46Z
dc.date.available2022-10-18T21:54:44Z
dc.date.created2018-12-07T13:32:46Z
dc.date.issued2018
dc.identifierhttp://hdl.handle.net/10533/232031
dc.identifier1150194
dc.identifierWOS:000444207800024
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4463386
dc.description.abstractFailure in fear extinction is one of the more troublesome characteristics of posttraumatic stress disorder (PTSD). Cotinine facilitates fear memory extinction and reduces depressive-like behavior when administered 24 h after fear conditioning in mice. In
dc.languageeng
dc.relationhttps://www.ncbi.nlm.nih.gov/pubmed/29488138
dc.relationhandle/10533/111557
dc.relation10.1007/s12035-018-1095-8
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleIntranasal cotinine plus krill oil facilitates fear extinction, decreases depressive-like behavior, and increases hippocampal calcineurin a levels in mice (vol 55, pg 7949, 2018)
dc.typeArticulo


Este ítem pertenece a la siguiente institución